Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender differences in psychotropic medications

F Lewis-Hall1

  • 1Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46225, USA.

The Mount Sinai Journal of Medicine, New York
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PCAST report: impact and implications for the pharmaceutical industry.

Clinical pharmacology and therapeutics·2013
Same author

The African-American community.

Women's health issues : official publication of the Jacobs Institute of Women's Health·1994
Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012
Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012
Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012
Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012
Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012
Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012
See all related articles

Gender significantly impacts psychotropic medication use, influencing prevalence and treatment. Further research is needed on gender-specific efficacy, dosage, and side effects due to pharmacokinetic and pharmacodynamic differences.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Gender Studies

Background:

  • Pharmacological research has advanced understanding of psychotropic medication prescription.
  • Patient gender is an increasingly recognized variable influencing psychiatric disease prevalence, symptom presentation, and treatment-seeking behavior.
  • Significant gender differences are observed in the receipt of psychotropic medication.

Purpose of the Study:

  • To review existing literature on the impact of gender on psychotropic medications.
  • To identify gaps in knowledge regarding gender-specific efficacy, dosage, and side effects.
  • To make recommendations for future research in this field.

Main Methods:

  • Literature review of studies investigating gender and psychotropic medications.

Related Experiment Videos

  • Analysis of pharmacokinetic and pharmacodynamic properties in relation to gender.
  • Consideration of psychosocial, environmental, genetic, and hormonal influences.

    • Main Results:

    • Significant gender differences exist in psychiatric disease prevalence, symptom presentation, and treatment-seeking behavior.
    • Gender influences the receipt of psychotropic medication.
    • Limited research exists on gender differences in psychotropic medication efficacy, dosage, and side effects.

    Conclusions:

    • A significant gap exists in understanding gender-specific effects of psychotropic medications.
    • Further research is crucial to address potential clinical implications of gender differences.
    • Future studies should consider a multifactorial approach including psychosocial, environmental, genetic, and hormonal factors.